Your browser doesn't support javascript.
loading
No Change in Determining Crohn's Disease Recurrence or Need for Endoscopic or Surgical Intervention With Modification of the Rutgeerts' Scoring System.
Rivière, Pauline; Vermeire, Séverine; Irles-Depe, Marie; Van Assche, Gert; Rutgeerts, Paul; de Buck van Overstraeten, Anthony; Denost, Quentin; Wolthuis, Albert; D'Hoore, Andre; Laharie, David; Ferrante, Marc.
Afiliação
  • Rivière P; Department of Gastroenterology and Hepatology, University Hospitals Leuven, KU Leuven, Leuven, Belgium; Department of Hepatogastroenterology and Digestive Oncology, Haut-Lévêque Hospital, CHU de Bordeaux, Bordeaux, France.
  • Vermeire S; Department of Hepatogastroenterology and Digestive Oncology, Haut-Lévêque Hospital, CHU de Bordeaux, Bordeaux, France.
  • Irles-Depe M; Department of Gastroenterology and Hepatology, University Hospitals Leuven, KU Leuven, Leuven, Belgium.
  • Van Assche G; Department of Hepatogastroenterology and Digestive Oncology, Haut-Lévêque Hospital, CHU de Bordeaux, Bordeaux, France.
  • Rutgeerts P; Department of Hepatogastroenterology and Digestive Oncology, Haut-Lévêque Hospital, CHU de Bordeaux, Bordeaux, France.
  • de Buck van Overstraeten A; Department of Abdominal Surgery, University Hospitals Leuven, KU Leuven, Leuven, Belgium.
  • Denost Q; Department of Abdominal Surgery, Haut-Lévêque Hospital, CHU de Bordeaux, Bordeaux, France.
  • Wolthuis A; Department of Abdominal Surgery, University Hospitals Leuven, KU Leuven, Leuven, Belgium.
  • D'Hoore A; Department of Abdominal Surgery, University Hospitals Leuven, KU Leuven, Leuven, Belgium.
  • Laharie D; Department of Gastroenterology and Hepatology, University Hospitals Leuven, KU Leuven, Leuven, Belgium.
  • Ferrante M; Department of Hepatogastroenterology and Digestive Oncology, Haut-Lévêque Hospital, CHU de Bordeaux, Bordeaux, France. Electronic address: marc.ferrante@uzleuven.be.
Clin Gastroenterol Hepatol ; 17(8): 1643-1645, 2019 07.
Article em En | MEDLINE | ID: mdl-30291910
The postoperative endoscopic recurrence score, commonly referred to as the Rutgeerts score, was designed to predict clinical recurrence risk in Crohn's disease (CD) patients undergoing ileocolonic resection based on early endoscopic findings at the anastomosis and in the neoterminal ileum.1 In the pivotal publication, the i2 category, including aphthous lesions in the terminal ileum as well as ileocolonic anastomosis lesions, had a heterogeneous recurrence risk. Because anastomotic ulcers were suspected to be postsurgical ischemic lesions and less predictive of progressive disease,2 a modified Rutgeerts score (mRS) was proposed: i2a, lesions confined to the anastomosis ±<5 isolated aphthous ulcers in the ileum; i2b, more than 5 aphthous ulcers in the ileum with normal mucosa in between, ± anastomotic lesions.3,4.
Assuntos

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Doença de Crohn / Colonoscopia / Colectomia / Íleo Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Clin Gastroenterol Hepatol Assunto da revista: GASTROENTEROLOGIA Ano de publicação: 2019 Tipo de documento: Article País de afiliação: França

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Doença de Crohn / Colonoscopia / Colectomia / Íleo Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Clin Gastroenterol Hepatol Assunto da revista: GASTROENTEROLOGIA Ano de publicação: 2019 Tipo de documento: Article País de afiliação: França